Announcement on Voluntary Disclosure of the Latest Research Results of Multiple Oncology Pipelines Selected for 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

About this update from Innocare Pharma Ltd. Class A

Announcement on Voluntary Disclosure of the Latest Research Results of Multiple Oncology Pipelines Selected for 2025 American Society of Clinical Oncology (ASCO) Annual MeetingThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Innocare Pharma Ltd. Class A